KeyNeurotek Pharmaceuticals' Series C Round

KeyNeurotek Pharmaceuticals raised a round of funding on April 10, 2009.

KeyNeurotek Pharmaceuticals is a clinical stage small molecule company focused on autoimmune and CNS diseases.…

Articles about KeyNeurotek Pharmaceuticals' Series C Round: